Treatment of recurrent aphthous stomatitis with clofazimine

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 108, Issue 5, 2009, Pages 714-721

  de Abreu, Marilda Aparecida Milanez Morgado ^a   Hirata, Cleonice Hitomi Watashi ^b   Pimentel, Dalva Regina Neto ^b   Weckx, Luc Louis Maurice ^b  

^a University Paulista   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; APHTHOUS STOMATITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLOFAZIMINE; COLCHICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SINGLE-BLIND METHOD; STOMATITIS, APHTHOUS; YOUNG ADULT;

EID: 72149097625     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.05.009     Document Type: Article

References (34)

1. Ship J.A. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (1996) 141-147
2. Vincent S.D., and Lilly G.E. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 74 (1992) 79-86
3. Kruger B.J. T-Lymphocyte subset changes in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 60 (1985) 175-181
4. Insel R. Alterations of T helper/inducer and T suppressor/inducer cells in patients with recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 69 (1990) 205-208
5. H2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med 33 (2004) 140-146
6. Hasan A., Shinnick T., Mizushima Y., van der Zee R., and Lehner T. Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis. Clin Exp Immunol 128 (2002) 318-325
7. Ruah C.B., Stram J.R., and Chasin W.D. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 114 (1988) 671-675
8. Altinor S., Oztürkcan S., and Hah M.M. The effects of colchicine on neutrophil function in subjects with recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 17 (2003) 469-470
9. Wray D., and Charon J. Polymorphonuclear neutrophil function in recurrent aphthous stomatitis. J Oral Pathol Med 20 (1991) 391-394
10. Barrons R.W. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 58 (2001) 41-52
11. Katz J., Langevitz P., Shemer J., Barak S., and Livneh A. Prevention of recurrent aphthous stomatitis with colchicine: an open trial. J Am Acad Dermatol 31 (1994) 459-461
12. Fontes V., Machet L., Huttenberger B., Lorette G., and Vaillant L. Aphtose buccale récidivante: traitement par colchicine. Etude ouverte de 54 cas. Ann Dermatol Venereol 129 (2002) 1365-1369
13. Eisenbud L., Horowitz I., and Kay B. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 64 (1987) 289-292
14. Revuz J., Guillaume J.C., Janier M., Hans P., Marchand C., Souteyrand P., et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 126 (1990) 923-927
15. De Cree J., Verhaegen H., De Cock W., and Verbruggen F. A randomized double-blind trial of levamisole in the therapy of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 45 (1978) 378-384
16. Sun A., Wang J.T., Chia J.S., and Chiang C.P. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations. Oral Pathol Med 35 (2006) 111-116
17. Sun A., Chia J.S., Chang Y.F., and Chiang C.P. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations. J Oral Pathol Med 32 (2003) 206-214
18. Weckx L.L., Hirata C.H., de Abreu M.A., Fillizolla V.C., and da Silva O.M. Levamisol não previne lesões de estomatite aftosa recorrente: um ensaio clínico randomizado, duplo-cego e controlado por placebo. Rev Assoc Med Bras 55 (2009) 132-138
19. Chandrasekhar J., Liem A.A., Cox N.H., and Paterson A.W. Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 (1999) 564-567
20. Thornhill M.H., Baccaglini L., Theaker E., and Pemberton M.N. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 143 (2007) 463-470
21. Kumar B., Kaur S., Kaur I., and Gangowar D.N. More about clofazimine-3 years experience and review of literature. Indian J Lepr 59 (1987) 63-74
22. Kumar B. Clofazimine-a review. Indian J Lepr 63 (1991) 78-92
23. Holdiness M.R. Clinical pharmacokinetics of clofazimine. A review. Clin Pharmacokinet 16 (1989) 74-85
24. Arbiser J.L., and Moschella S.L. Clofazimine: a review of its medical uses and mechanisms of action. J Am Acad Dermatol 32 (1995) 241-247
25. Anderson R., Lukey P., Van Rensburg C., and Dippenaar U. Clofazimine-mediated regulation of human polymophonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness. Int J Immunopharmacol 8 (1986) 605-620
26. Baranda L., Torres-Alvarez B., Cortes-Franco R., Moncada B., Portales-Perez D.P., and Gonzalez-Amaro R. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch Dermatol 133 (1997) 325-329
27. Brandt L. Enhancing effect of clofazimine (B663) on the phagocytosis of neutrophilic leucocytes in vitro. Scand J Haematol 8 (1971) 265-269
28. Anderson R., and Smit M.J. Clofazimine and B669 inhibit the proliferative responses and Na+,K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism. Biochem Pharmacol 46 (1993) 2029-2038
29. Krajewska M.M., Anderson R., and O'Sullivan J.F. Effects of clofazimine analogues and tumor necrosis factor-alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro. Int J Immunopharmacol 15 (1993) 99-111
30. Costa Queiroz R.H., de Souza A.M., Sampaio S.V., and Melchior Jr. E. Biochemical and hematological side effects of clofazimine in leprosy patients. Pharmacol Res 46 (2002) 191-194
31. Levi M., Spino M., and Read S.E. Colchicine: a state-of-the-art review. Pharmacotherapy 11 (1991) 196-211
32. In: Agresti A. (Ed). Categorical data analysis (1990), Wiley, New York 558
33. In: Sprent P. (Ed). Applied nonparametric statistical methods. 2nd ed. (1993), Chapman and Hall, London 342
34. Kutner M.H., Nachtsheim C.J., Neter J., and Li W. Applied linear statistical models. 5th ed. (2004), McGraw-Hill/Irwin, New York 1396